Dehydrodiisoeugenol targets NOD2 exerting dual effects against colitis and colorectal cancer: a double-edged sword
Abstract Dehydrodiisoeugenol (DEH) is a primary benzofuran-type neolignan isolated from the Chinese herbal medicine nutmeg, which is used in the treatment of gastrointestinal diseases. This study aims to observe the dual therapeutic effects of DEH on DSS-induced ulcerative colitis (UC) and colorecta...
Saved in:
| Main Authors: | Feiyang Yi, Nianzhi Chen, Maoyuan Zhao, Zhili Gu, Yun Yuan, Xuegui Tang, Fang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01193-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle
by: Lin Li, et al.
Published: (2025-02-01) -
Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01) -
Dehydrodiisoeugenol alleviates palmitate-induced mitochondrial dysfunction in human vascular smooth muscle cells through the activation of SIRT1-mediated Drp1 deacetylation
by: Jianjun Zhao, et al.
Published: (2025-05-01) -
Retinoic acid differently modulates NOD1/NOD2-mediated inflammatory responses in human macrophage subsets
by: Hala Ahmad, et al.
Published: (2025-07-01) -
A nod to paratuberculosis: NOD1 and NOD2 expression in the pathological spectrum of Mycobacterium avium subsp. paratuberculosis infection in cattle
by: David Zapico, et al.
Published: (2025-05-01)